Cognito Therapeutics Partners with Initiative to Change the "D-Word," Commits to Eliminating Use of "Dementia" Across All Communications ...

Cognito Therapeutics is partnering with a nonprofit to “Change the D-Word,” aiming to eliminate the use of “dementia,” a ...

US-based neurotechnology company Cognito Therapeutics has collaborated with Ochsner Health to establish the Brain Health ...

Cognito Therapeutics announced today that it entered into a collaboration with Ochsner Health to advance new approaches to ...

Expecting pivotal data this year, the company has raised a Series C round to support the launch of a noninvasive device designed to treat brain diseases using light and sound.

Cognito Therapeutics has spent the better part of the last decade developing neuromodulation technology that it claims could stop and even reverse the progression of Alzheimer’s and other ...

Cognito Therapeutics, a late clinical-stage neurotechnology company pioneering non-invasive neuroprotective therapies in ...

Riding high on early clinical trial results showing that its neuromodulation headset can improve memory and cognition and slow the deterioration of white matter in the brains of people with ...

Alzheimer's disease is a complicated and debilitating disease that has no cure. One startup is testing whether a "disco" of light and sound can slow the disease in patients. Cognito Therapeutics ...